MAI Capital Management
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1040197
INDEPENDENCE, OH
Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,800,563
+$1,810,138 QoQ
Shares Held
5,638
+154.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#592
of 1,732 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MAI Capital Management holds $23,665,100 across 54 Biotechnology names. VRTX ranks #2 (11.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6,715 | $4,187,071 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
5,638 | $2,800,563 | |
| 3 | DNLI |
Denali Therapeutics Inc.
|
49,160 | $1,264,394 | |
| 4 | INCY |
Incyte Corp
|
10,126 | $1,147,882 | |
| 5 | TRVI |
Trevi Therapeutics, Inc.
|
56,130 | $1,046,824 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
5,147 | $963,929 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
2,963 | $936,574 | |
| 8 | EXEL |
Exelixis, Inc.
|
13,982 | $760,760 |
All Filings in VRTX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,800,563 | 5,638 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $990,425 | 2,218 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,162,415 | 2,564 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $722,967 | 1,846 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $946,940 | 2,127 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $929,884 | 1,918 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $763,519 | 1,896 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,124,563 | 2,418 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,705,203 | 3,638 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,413,291 | 3,381 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,105,113 | 2,716 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $870,740 | 2,504 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,008,222 | 2,865 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $956,237 | 3,035 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $874,425 | 3,028 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $740,643 | 2,558 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $646,989 | 2,296 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $622,935 | 2,387 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $387,594 | 1,765 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $300,563 | 1,657 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||